Research and Development
Amarna Therapeutics and NorthX Biologics collaborate to advance gene therapy for type 1 diabetes
July 10, 2025 Mergers and Acquisitions, Research and Development Amarna Therapeutics, Diabetes, Immunology, NorthX Biologics, Type 1 diabetes, gene therapy, immune-mediated diseases
Eppendorf Award for Young European Investigators 2025 awarded to neuroscientist Varun Venkataramani
July 10, 2025 Medical Communications, Medical/ Scientific Writing, Research and Development Neurology, Oncology
First malaria medicine for infants under 4.5kg receives approval
July 9, 2025 Medical Communications, Research and Development Coartem Baby, Infections and infestations, Medicines for Malaria Venture, Novartis, Paediatrics, Swissmedic, malaria
Richard Philipson appointed as chief medical officer of Hansa Biopharma
July 9, 2025 Research and Development Hansa Biopharma, Immunology, chief medical officer, immunology
Ciloa secures €6.5m from French government to advance obesity and T2 diabetes therapy
July 9, 2025 Research and Development Ciloa, Diabetes, France 2030, Obesity, adiponectin, funding, obesity, type 2 diabetes
Duke Street Bio receives FDA fast track designation for brain metastases treatment
July 8, 2025 Medical Communications, Research and Development Duke Street Bio, Oncology, US Food and Drug Administration, brain metastases, breast cancer, fast track designation
SMC recommends Eladynos for postmenopausal osteoporosis in Scotland
July 8, 2025 Medical Communications, Research and Development Musculo-skeletal disorder, NHS, Scottish Medicine Consortium, Theramex, clinical trials, osteoporosis, postmenopause
Pila Pharma raises SEK 20m to advance new oral obesity treatment
July 8, 2025 Research and Development Novo Nordisk, Obesity, Ozempic, Pila Pharma, Wegovy, obesity, semaglutide, type 2 diabetes
HeartBeat.bio and biotx.ai partner to develop new drugs for heart failure
July 7, 2025 Mergers and Acquisitions, Research and Development AI, Cardiology, HeartBeat.bio, biotx.ai, heart failure
The Problem of Endometriosis in the UK
July 7, 2025 Research and Development NHS, Obstetrics & Gynaecology, Pain, Reproductive health, Theramex, endometriosis, gynaecology
FDA grants accelerated approval for advanced non-small cell lung cancer treatment
July 4, 2025 Medical Communications, Research and Development Breakthrough Therapy Designation, Oncology, US Food and Drug Administration, Zegfrovy, clinical trial, non-small cell lung cancer, priority review
Johnson & Johnson seeks EMA approval to accelerate prostate cancer treatment
July 4, 2025 Medical Communications, Research and Development European Medicines Agency, Genito-Urinary system, Johnson & Johnson, Oncology, clinical trial, prostate cancer
Biocon Biologics gains EU approval for bone health therapies
July 4, 2025 Market Access, Medical Communications, Research and Development Biocon Biologics, Committee for Medicinal Products for Human USE, European Commission, Evfraxy, Oncology, Orthopaedics, Osteoporosis, Vevzuo, bone health, osteoporosis, prostate cancer
Ferring strengthens evidence for flexible dosing of follitropin delta in IVF
July 3, 2025 Research and Development Ferring Pharmaceuticals, IVF, Reproductive health, clinical trial, fertility treatment, in vitro fertilisation, ovarian hyperstimulation syndrome, pregnancy, reproductive health, reproductive medicine
Carthera receives EMA endorsement for orphan medical device status of SonoCloud
July 2, 2025 Medical Communications, Research and Development Brain disorders, Breakthough Device Designation, CE marking, Carthera, Devices, European Medicines Agency (EMA), Food and Drug Administration, Forfait Innovation Status, Neurology, Orphan Medical Device Status, ultrasound imaging
Latest content
Acumentis CEO Herspiegel steps down as Burden assumes role
